Source link : https://europ.info/2025/10/02/greenwich-lifesciences-expands-flamingo-01-clinical-trial-to-belgium/
Greenwich LifeSciences has announced a significant expansion of its Flamingo-01 clinical trial, extending its research efforts into Belgium. The move marks a strategic step in the company’s ongoing commitment to advancing innovative treatments in oncology, broadening the trial’s geographic reach and patient diversity. This development was confirmed in a recent statement, highlighting Greenwich LifeSciences’ dedication to accelerating clinical progress and generating robust data that could potentially benefit cancer patients worldwide.
Greenwich LifeSciences Extends Flamingo-01 Trial to Belgium Enhancing European Research Collaboration
Greenwich LifeSciences has announced a strategic extension of its Flamingo-01 clinical trial into Belgium, marking a significant step forward in its commitment to advancing innovative therapies across Europe. This expansion enables the trial to leverage Belgium’s robust medical infrastructure and experienced research institutions, thereby accelerating patient recruitment and data collection. The move underscores Greenwich’s dedication to fostering transnational research partnerships that enrich clinical outcomes and enhance the scientific community’s collective understanding of the treatment’s efficacy.
Key advantages driving this expansion include:
- Access to diverse patient populations that improve the trial’s demographic representation.
- Collaboration with leading Belgian clinical centers, boosting trial management…
—-
Author : Victoria Jones
Publish date : 2025-10-02 14:55:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8